Jacobs Solutions

Phase A — Understand the business

Lens 1 · Company Overview

Jacobs Solutions Inc. (Dallas, TX; NYSE: J; ~75-year-old firm, ~43,000 employees, operating in 40+ countries) is a professional-services company delivering engineering, design, architecture, construction management, O&M, and digital/technical consulting. It earns revenue under cost-reimbursable and fixed-price contracts across a diversified base of government, industrial and commercial clients — it is a labor/expertise business, not a capital-asset business (capex was only ~$79M on $12.0B revenue in FY2025 — an asset-light model).

Two reportable segments post-reorganization:

• Infrastructure & Advanced Facilities (I&AF) — ~89% of revenue. The core E&C engine: water, transportation, environmental, energy-transition, life-sciences, semiconductor, and advanced facilities including data centers. FY2025 external revenue $10,764.2M.
• PA Consulting — ~11% of revenue, but the high-margin crown jewel. A UK-based management/strategy/innovation consultancy. FY2025 external revenue $1,265.6M. As of March 2026, 100% Jacobs-owned (see Lens 5).

The transformational event: On Sept 27, 2024, Jacobs completed a Reverse Morris Trust spin-off of its Critical Mission Solutions (CMS) + Cyber & Intelligence government-services businesses, merging them with Amentum (Jacobs holders got 51% of Amentum; Jacobs retained a ~7.5% stake). This deliberately shed lower-margin, gov-heavy work to become a "simpler, more focused, higher-margin" company. Result: US federal government fell to just 8% of FY2025 revenue (from 10% FY2024) — Jacobs is now overwhelmingly a commercial-and-infrastructure services firm, not a defense/gov contractor.

Contract structure: Mix of cost-reimbursable (lower-risk, cost-plus) and fixed-price (margin upside but execution risk). Backlog $23.1B at FY2025-end (+$1.2B YoY); remaining performance obligations (ASC 606) $15.7B, 51% recognizable within 12 months. Record backlog $27.0B (+22% YoY) reported at Q2-FY2026 — a leading indicator pointing up.

Lens 2 · Supply Chain

For a services firm, the "supply chain" is talent in → billable expertise → delivered project, plus the physical construction chain it orchestrates on behalf of owners. Named stakeholders along the chain:

• Upstream inputs: Engineering/technical labor (the binding constraint — see Lens 3), subcontractors, and procured equipment/materials that flow through as pass-through cost (the ~$3.3B gap between gross and net revenue). Jacobs is the orchestrator, not the buyer of record on most hardware.
• The company: Jacobs provides design, engineering, program management and, on marquee data-center jobs, EPCM (Engineering, Procurement & Construction Management).
• Downstream end customers (named):
• Data centers / AI infra: NVIDIA (co-developed a Data-Center Digital-Twin on the NVIDIA Omniverse DSX blueprint), Hut 8 (~$10B hyperscale AI data-center program, EPCM + digital twin), PsiQuantum (high-performance-computing environments).
• Water/transport/environment: government agencies, municipalities and utilities across the US, UK, Middle East, ANZ.
• Life-sciences / semiconductor: advanced-manufacturing owners (the "Advanced Facilities" franchise).
• Chokepoint / single-source dependency: The scarce input is specialized engineering headcount — mission-critical/data-center design talent in particular. Jacobs' edge is the installed base of that talent (decades of advanced-facility delivery); its risk is wage inflation and poaching. There is no physical single-source chokepoint (asset-light), which is a structural positive.

Lens 3 · Competitive Advantages (moats)

Jacobs competes with AECOM, WSP Global, Stantec, Tetra Tech, Fluor, Arcadis, Mott MacDonald and others. Durable moats:

1. Scale + reference base in advanced facilities. As AI data centers scale to gigawatt size, owners want certainty before committing capital — a firm that has "delivered the world's most advanced facilities for decades" is a shortlist of a handful globally. This is a reputation/track-record moat that is hard to replicate and is exactly what is being monetized now (CEO: the DC "investment cycle is still in early stages").
2. Switching costs mid-program. Once Jacobs is embedded on a multi-year design/EPCM program (backlog $27B), swapping the engineer of record is costly and risky for the owner — sticky, multi-year revenue.
3. PA Consulting = a differentiated, higher-value moat. A management-consulting arm most pure-play E&C peers lack, letting Jacobs sell strategy + digital + engineering together at consulting-grade (~22%) margins.
4. Digital/IP layer. Proprietary tools — Data-Center Digital Twin (NVIDIA Omniverse), Evolve, Climate Risk Manager, Intelligent O&M — push Jacobs up the value chain from "hours" toward "technology-enabled outcomes".

Bargaining power: Modest. This is a competitive-procurement business; contracts are won on price, schedule and technical sophistication, and the 10-K explicitly flags that competition "can place downward pressure on our contract prices and profit margins". Jacobs has power over subcontractors and pricing power in scarce-skill niches (mission-critical/DC), but limited power over large sophisticated buyers (hyperscalers, governments). The moat is relative (better shortlist position than most peers), not monopolistic.

Lens 4 · Segments

All segment figures ``.

By segment — 3-year revenue & segment operating profit (external customers, $M):

Trend & cause:

• I&AF growing mid-single-digits on GAAP revenue with expanding segment margin (7.6% → 7.7% → 8.4%). FY2025 growth "mainly driven by the Company's I&AF business… stronger performance in its Advanced Facilities and APME operations". Advanced Facilities (semis, life sciences, data centers) is the accelerant.
• PA Consulting is the margin engine: ~22% segment margin vs I&AF's ~8%. FY2025 revenue +7.5% and OP +16.4% — accelerating and mix-accretive. Owning 100% of PA (from March 2026) captures more of this profit for Jacobs shareholders.
• Reconciliation to GAAP: Total segment OP $1,182.0M reconciles down to GAAP operating profit $863.6M via restructuring/transaction charges (−$162.9M) and intangible amortization (−$155.5M).

By geography (FY2025 GAAP revenue, $M): United States $7,415.5 (62%), Europe $2,871.6 (24%), Middle East & Africa $596.3, Australia/NZ $573.2, Canada $248.1, India $180.1, Asia $144.9. Heavily US/Europe weighted. US federal government = only 8% of total — the Amentum spin structurally de-risked government-shutdown / budget exposure.

---

Phase B — Measure performance

Lens 5 · Earnings Result

The story of the last two prints is one number that looks alarming and isn't: a Q2-FY2026 GAAP operating loss that is 100% a deal-charge artifact, sitting on top of an operating business that is accelerating.

FY2025 (full year, ended 2025-09-26) — the first clean post-spin year:

• GAAP revenue $12,029.8M (+4.6% YoY); gross profit $2,984.9M (24.8% margin, +20bps); GAAP operating profit $863.6M (+24.7% YoY, 7.2% margin).
• Net earnings to Jacobs from continuing ops $313.3M, diluted EPS $2.58 — down 48.9% vs FY2024's $4.79. The decline is optical: FY2024 continuing EPS was inflated by a +$186.9M mark-to-market gain on the retained Amentum stake, whereas FY2025 booked a −$227.3M mark-to-market loss on that same stake plus a $20.5M debt-extinguishment loss. Strip the Amentum-stake noise and operating profit rose ~25%.
• Non-GAAP (the number management/Street watch): Adjusted net revenue $8.7B (+5.3%), Adjusted EBITDA $1.2B (+13.9%), Adjusted EPS $6.12 (+15.9%). Adjusted EBITDA growing ~3x faster than GAAP revenue = the margin-mix thesis working.
• Balance sheet FY2025-end: cash $1,235.4M, total debt $2,236.5M → net debt ~$1,001M. Goodwill $4,780.8M = 42% of total assets (CH2M + PA legacy) — a watch item, not yet an impairment. Operating cash flow $686.7M, down from $1,054.7M FY2024 (working-capital build in receivables, −$177.9M) — the one genuine yellow flag in FY2025.
• Backlog $23.1B (+$1.2B); $754.1M of stock repurchased with $1.22B remaining authorization.

Q2-FY2026 (quarter ended 2026-03-27) — the print that needs decoding:

• GAAP revenue $3,694.9M (+27% YoY) — the jump reflects PA now fully consolidated + organic growth. Gross profit $794.9M.
• GAAP operating LOSS $(81.2)M vs +$208.6M prior year; net loss to Jacobs $(45.9)M; diluted EPS $(0.32) continuing / $(0.34) total.
• Why: SG&A ballooned to $876.1M (+65% YoY) because Q2 absorbed ~$207.0M of incremental one-time PA Consulting Transaction charges — mainly full vesting of PA equity-incentive grants plus $123.9M of accrued PA employee-benefit-trust distributions — plus $352.2M of total restructuring/transaction/other charges below the segment line. Segment operating profit was actually healthy: I&AF $225.2M + PA $79.9M = $305.1M. The GAAP loss is entirely the deal cost; the underlying business made money.
• Proof it's Q2-specific: the six-month figures are positive — net income $79.6M, diluted EPS +$0.79.
• Non-GAAP (what the market traded on): Adjusted EPS $1.75 vs $1.63 est (+7% beat), +22.4% YoY; adjusted net revenue $2.33B (+8.8% YoY, +2% beat). Record backlog $27.0B (+22%). Data-center revenue +100%+ YoY, pipeline +400%; AI-infra ecosystem now 10–11% of the business, growing >40%.
• Guidance raised for the 2nd straight quarter: FY2026 adjusted net-revenue growth 8.0–10.5% (was 6.5–10.0%), adj EBITDA margin 14.6–14.9%, adjusted EPS $7.10–$7.35 (was $6.95–$7.30), adj FCF margin 7.0–8.5%.

Market reaction: modestly positive (~+2.4% after-hours) — the adjusted beat + guidance raise + record DC backlog outweighed the headline GAAP loss, i.e. the market correctly looked through the PA charge.

Unusual-vs-history flags: (1) the two Amentum-stake marks (+$187M / −$227M) that whipsaw GAAP net income; (2) the Q2 one-time PA charges; (3) the FY2025 OCF decline on receivables build; (4) net debt roughly tripling to ~$2.7B post-PA buyout (Lens 9/10).

Lens 6 · Earnings Calls (sentiment trend)

No transcripts on the research-layer shelf (transcripts/ empty; ingest not run per task scope). Sentiment reconstructed from filing MD&A + earnings coverage ``, so treat as directional.

• Tone: consistently and increasingly bullish, with a clear pivot to AI/data-center as the lead narrative. Management launched "Challenge Accepted" (Feb 2025 investor day) as the multi-year growth story, and by Q2-FY2026 the framing is explicitly AI-infrastructure-led.
• What they keep saying: "simpler, more focused, higher-margin company"; "positioned across the entire infrastructure ecosystem"; data-center cycle "still in early stages"; "profitable growth" + "strong balance sheet." Recurring metric emphasis on adjusted net revenue, adjusted EBITDA margin, and organic growth — a deliberate steer away from noisy GAAP.
• What they stopped saying: government/defense-mission framing (shed with Amentum) and Amentum-stake commentary (monetized/wound down — the retained equity-securities line went to $0 on the FY2025 balance sheet).
• Shift over time: FY2024 calls = "executing the separation"; FY2025 = "clean focused company, margin expansion"; FY2026 = "AI-infra supercycle, DC +100%, pipeline +400%, raising guidance." The narrative has moved from portfolio surgery to secular growth — a healthy progression, but it also means expectations (and the multiple) now embed the DC ramp.

Lens 7 · Comps

Peer set: global engineering/consulting firms. Multiples are ``, dated; where a specific figure wasn't sourced it is marked n/a. Do not treat any cell as filing-grade.

Read: The peer group (Jacobs, Tetra Tech, Stantec, WSP) trades ~13.3x EV/adjusted EBITDA on average. Jacobs at ~14.2x sits at/slightly above the peer average and roughly in line with WSP — i.e. fully valued, not cheap. AECOM is the value outlier (9.5x FY26E) despite higher margins, which is the single most obvious relative-value flag against owning Jacobs here: a skeptic would ask why pay a premium multiple for J when ACM is cheaper on superior margins. Jacobs' premium is defensible only if its DC/AI-infra mix and PA-consulting margins compound faster than peers — the bull thesis in one line. FY26E fwd P/E on the adjusted EPS midpoint ($7.22) at $125.58 is ~17.4x, a reasonable-not-cheap multiple for a mid-teens EPS grower.

Lens 8 · Stock-Price Catalysts (5-yr, >5% moves)

Mostly ; pattern analysis is from the reconstructed history.

• Total returns: 2021 +28.8%, 2022 −13.0%, 2023 +9.2%; ~5-yr avg ~10.5%/yr.
• The dominant multi-year catalyst = portfolio transformation, not any single earnings print:
• Dec 2017: Closed CH2M acquisition ($3.27B EV) — created a ~$15B professional-services leader; the deal that built today's water/environmental scale.
• Nov 2023 → Sept 2024: Announced and completed the Amentum Reverse Morris Trust spin — the re-rating catalyst that turned J from a gov-heavy contractor into a focused, higher-margin services firm.
• Feb 2025: "Challenge Accepted" investor day (6–8% organic net-rev growth, 16%+ EBITDA margin by FY29) — reset the growth framing.
• Nov 2025 (Q4/FY25): Beat + margin expansion; but analysts cut forecasts on some line items post-print — a reminder expectations are demanding.
• Jan–Mar 2026: £1.2B PA Consulting buyout + debt financing — the event driving the Q2 GAAP loss and the balance-sheet re-leveraging.
• May 2026 (Q2): Adjusted beat, 2nd guidance raise, record $27B backlog + DC +100%/pipeline +400% — the AI-infra narrative crystallized; stock +2.4% after-hours.
• What the market actually reacts to (pattern): (1) portfolio/strategic actions (spins, big M&A) move the multiple the most; (2) backlog + organic-growth + adjusted-EBITDA-margin beats/raises move it quarter-to-quarter; (3) it looks through GAAP noise (Amentum marks, PA charges) to adjusted numbers. It is not a name that trades on a single customer or on macro rates the way a cyclical would — it trades on mix-shift toward higher-margin, higher-growth end-markets (AI/DC) and on capital-allocation credibility.

---

Phase C — Judge people & books

Lens 9 · Management

• CEO: Bob Pragada — CEO since Jan 2023 (~3.4 yrs), also Chair. 17 years at Jacobs (SVP Global Sales → GVP → COO Nov-2019 → CEO), with an outside stint as President/CEO of the Brock Group and COO at Kinetics (semiconductor/pharma-bio process solutions — directly relevant to the Advanced Facilities franchise). Ex-US Navy Civil Engineer Corps / Seabees officer (9 yrs).
• Track record (quantified): (1) Co-led the CH2M integration — cited internally as the largest, "highly successful" acquisition in Jacobs' history; (2) executed the Amentum Reverse Morris Trust spin cleanly (tax-free, on schedule) — genuine portfolio surgery that lifted margins and cut gov exposure to 8%; (3) drove adjusted EPS +15.9% (FY25) and +22.4% (Q2-FY26) with two consecutive guidance raises. This is a management team that has delivered structural value, not just ridden the cycle.
• Skin in the game: Pragada owns ~0.23% (~$32M) directly. Meaningful in dollars, modest as a % — professional-manager, not founder-owner, ownership. No insider-transactions.csv on the shelf to assess recent buy/sell behavior — a gap; a targeted refresh should ingest it.
• Capital-allocation history: Disciplined and shareholder-friendly, but just levered up. FY2025: $754.1M buybacks ($1.22B remaining auth) + a growing dividend (~1.08% yield). Then the £1.2B PA buyout (mostly cash + debt) — a high-conviction bet on the highest-margin asset it already owned, which is strategically sound (captures 100% of ~22%-margin profit) but tripled net debt to ~$2.7B and consumed the balance-sheet cushion. The judgment call: buying out a crown-jewel minority at a full price vs. buybacks/de-levering. Defensible, but it removes optionality and raises execution stakes.
• Founder vs professional manager: Classic professional manager / operator-integrator archetype — exactly the right profile for a serial-acquirer services roll-up, but it means the thesis rests on continued disciplined capital allocation, not founder vision. No red flags on comp/related-party in the filings reviewed; strategy has been coherent (focus → higher margin → AI-infra), not promotional zig-zagging.

Lens 10 · Forensic Red Flags

Every figure labeled; sourced from the two filings + the regulatory file.

Accounting-risk map:

1. Goodwill/intangibles concentration — the biggest structural item. Goodwill $4,763–4,781M ≈ 42% of total assets ($11.9B). Legacy of CH2M + PA. No impairment taken, but a services firm carrying goodwill ~1.4x total equity ($3.29B) means any prolonged demand shock in I&AF or PA could force a write-down. Watch, not fail.
2. GAAP↔cash / non-GAAP-vs-GAAP divergence. Management steers hard to adjusted net revenue / adjusted EBITDA / adjusted EPS. The adjustments are large and recurring-ish (restructuring/transaction charges: −$162.9M FY25, −$352.2M in Q2-FY26 alone; intangible amortization −$155.5M FY25). FY2025 adjusted EPS $6.12 vs GAAP continuing $2.58 — a ~2.4x gap. Much of the gap is legitimately one-time (Amentum marks, PA-deal charges, amortization of acquired intangibles), but the sheer size and frequency of "one-time" items in a serial acquirer warrants skepticism — verify each add-back is genuinely non-recurring, not evergreen restructuring.
3. SBC. Stock-based comp $61.0M FY2025 (down from $74.2M) — modest (~0.5% of revenue), not a flatter-the-non-GAAP concern here. The PA equity-grant vesting ($207M) is a discrete event, now fully expensed ("no remaining unrecognized compensation costs… in the future").
4. Working capital / cash conversion. Receivables + contract assets rose to $3,555.6M at Q2-FY26 (from $2,989.1M); FY2025 OCF fell to $686.7M (from $1,054.7M) partly on a −$177.9M receivables build. For a services firm, watch DSO creep — it can flatter revenue recognition ahead of cash. Not alarming yet; trending the wrong way.
5. Leverage step-up. Long-term debt $2,236.5M → $4,084.2M (+$1,848M) between Sept-25 and Mar-26 to fund the PA buyout; redeemable NCI (the PA put liability) went to $0. Net debt ~$2.7B. Not distressed for a $1.2B-EBITDA business (~2.3x net-debt/adj-EBITDA ) but the cushion is gone.
6. Contingencies — the "Consolidated JV Matter." An unfavorable interim ruling against a 50%-owned consolidated JV required a reserve that dented I&AF revenue/OP in FY2025; the noncontrolling partner's share runs through NCI. Ongoing litigation/arbitration (personal injury, professional liability, breach of contract) is normal for E&C but the JV matter is a specific, unresolved item — monitor for adverse final ruling.

Regulatory findings (required sub-section):

• SEC Litigation Releases / AAERs: None. "No LR found" and "No AAER found" for Jacobs Solutions in the 2021-07-06→2026-07-06 window per SEC EDGAR EFTS.
• Non-SEC enforcement (web search): No material recent (2024–2026) DOJ/FTC/environmental enforcement surfaced. Historical only: a qui-tam False Claims Act matter alleging failure to meet employment-eligibility/drug-testing requirements on a $112M SOCOM IT contract (Jacobs Technology/Engineering) — complaint unsealed Jan-2020, the federal government declined to intervene. An older FCA matter re: rental-cost charging after a HQ sale-leaseback. FY2024: "no significant fines or non-monetary sanctions for environmental non-compliance". A Jacobs Engineering Group v. USA (Fed. Cl. 2024-cv-02053) contract dispute exists but appears to be Jacobs pursuing a claim, not a government enforcement action.
• 10-K Item 3 (Legal Proceedings): The 10-K discloses ordinary-course litigation typical of E&C (personal-injury, professional-liability, breach-of-contract) plus the Consolidated JV Matter and a non-US tax indemnity tied to the separated SpinCo business. No single item flagged as individually material to solvency.
• Verdict: No material regulatory or accounting-enforcement findings — verified via SEC EDGAR EFTS (LR, AAER), web search, and 10-K Item 3 as of 2026-07-06. The forensic risks are quality-of-earnings (non-GAAP add-back size, goodwill concentration, DSO creep, fresh leverage), not fraud.

---

Phase D — Project & stress-test

Lens 11 · Forward Projection

Built bottom-up from management's own guidance + segment trajectory. Fiscal years FY2026–FY2028 (FY ends late Sept). All outputs ``; anchored to the adjusted-EPS framework the company and Street use (GAAP EPS is too mark-distorted to project cleanly).

Anchor: FY2025 adjusted EPS $6.12; FY2026 guidance $7.10–$7.35 (midpoint ~$7.22). "Challenge Accepted" targets: 6–8% organic net-revenue growth FY25–29, 16%+ adj EBITDA margin and 10%+ FCF margin by FY29.

Reasoning: Jacobs is an operating-leverage + mix-shift story, not a volume story — GAAP revenue grows mid-single-digits, but adjusted EBITDA and EPS grow low-double-digits because (a) the mix tilts toward higher-margin PA + Advanced Facilities/DC, (b) PA is now 100% owned, and (c) buybacks shrink the share count (~118M and falling). The swing factor is how durably the AI-data-center pipeline (+400%) converts to billed net revenue — the entire premium multiple rests on it.

Forecast-tracker note: Per --watchlist rules, no forecast.ts create logged in the unattended loop (only log a Brier forecast on genuine committed conviction). The base call to hand to /thesis if promoted: "J FY2026 adjusted EPS ≥ $7.10 (within/above guidance), p≈0.80, resolves 2026-09-25."

Lens 12 · Bull vs Bear

Bull case. Jacobs is the highest-quality, most liquid, asset-light way to own the AI-infrastructure buildout without owning the compute or the megawatts — it sells the scarce engineering + program-management + digital layer that gigawatt-scale AI data centers cannot be built without. The moat is a decades-deep advanced-facilities reference base that puts it on a shortlist of a handful of firms hyperscalers (NVIDIA, Hut 8, PsiQuantum) will trust with multi-billion-dollar, must-not-fail projects. The engine is already inflecting: DC revenue +100% YoY, pipeline +400%, AI-infra 10–11% of the book growing >40%, record $27B backlog (+22%), two straight guidance raises. Layered on top: a genuinely differentiated ~22%-margin PA Consulting arm now 100% owned, buybacks ($1.22B auth) shrinking the count, and a management team with a proven record of value-accretive portfolio surgery (CH2M, the clean Amentum spin). Mid-teens adjusted-EPS growth on an asset-light, ~15% ROE-ish services model deserves a premium services multiple. If the DC cycle is truly "still in early stages" (CEO), FY28 adjusted EPS ~$9–10 is achievable and today's ~17x FY26 adj P/E is undemanding on out-year numbers.

Bear case (permanent-impairment risks).

1. The multiple already prices the DC ramp. At ~14.2x EV/EBITDA (above the ~13.3x peer average) and ~23% below a $155 median PT that itself assumes the AI-infra story, there is little margin of safety — a single quarter of DC pipeline not converting, or hyperscaler capex digestion, re-rates the stock down before earnings even fall. AECOM at ~9.5x on higher margins is a live "why own the expensive one?" alternative.
2. This is still a competitive-procurement services business with ~8% core-segment margins. The 10-K itself warns competition pressures price and margin; a services roll-up is only as good as its next contract win and its labor cost. It is not a franchise with pricing power — the moat is relative, not absolute.
3. Balance-sheet cushion just spent. Net debt tripled to ~$2.7B (~2.3x adj EBITDA) to buy out PA. That removes the optionality that made J resilient, and combined with goodwill at 42% of assets and the unresolved Consolidated JV Matter, a demand shock could hit both earnings and the balance sheet (write-down) at once.

Pre-mortem (18 months out, thesis broke): It's early 2028. Hyperscaler AI-capex growth decelerated through 2027 as GPU-supply and power constraints slowed data-center starts; Jacobs' +400% pipeline converted to backlog but slipped in the schedule, so billed net revenue on DC undershot. Legacy infrastructure/water grew only low-single-digits. The premium multiple compressed toward AECOM's; adjusted EPS came in at the bear ~$7.3 instead of ~$8+, and with net debt at ~2.5x, buybacks were paused. The stock is ~$100, and the "AI-infra picks-and-shovels" narrative that justified 17x is now "cyclical E&C at 12x."

Are multiples too high? Slightly. ~14x EV/EBITDA / ~17x FY26-adj P/E is fair for the growth if it materializes, but it is a full price with no cushion — a "great company, not-great entry point" setup.

Contrarian view (what the market is refusing to see): The consensus frames J as an "AI data-center play" and pays up for it — but the durable, under-appreciated value is PA Consulting + Advanced-Facilities margin mix, which compounds regardless of any single DC cycle. Conversely, the market may be under-pricing the risk that "one-time" restructuring/transaction add-backs are semi-permanent for a serial acquirer, making the ~2.4x GAAP-to-adjusted EPS gap less pristine than the bulls' models assume.

Lens 13 · Devil's Advocate (short-seller)

Dismantling the bull case:

• What structurally breaks the money-machine: Jacobs sells labor hours dressed up as outcomes. Strip the AI narrative and it's a low-single-digit-organic-growth, ~8%-core-margin, competitively-bid E&C firm whose GAAP earnings are a rounding error ($2.58 continuing EPS) after you stop believing the add-backs. The entire premium is the DC story — and DC is ~10% of the book. The other ~90% grows GDP-ish.
• Concentration risk: Not customer-concentrated (a positive), but thesis-concentrated on the AI-capex cycle and geography-concentrated (US 62% + Europe 24% = 86%). A US infrastructure-spending slowdown or a hyperscaler capex pause hits the growth engine directly.
• Why the moat is weaker than bulls think: It's a shortlist moat, not an exclusivity moat. AECOM, WSP, Fluor, and specialist mission-critical firms bid the same gigawatt jobs. On the very metric that matters (EV/EBITDA on superior margins), AECOM is ~33% cheaper — the market is already telling you J's premium is fragile.
• Most dangerous competitor bulls underestimate: AECOM — higher segment margins (~16.8% TTM), a cheaper multiple, and the same DC/advanced-facilities positioning. If capital rotates to "cheaper + better-margin," J de-rates.
• Worst capital-allocation move: Paying £1.2B (a full price) to buy out the PA minority with debt at the top of the cycle, tripling net debt and spending the cushion — right before a potential AI-capex digestion. If DC slows in 2027, that timing looks aggressive.
• Assumptions that must hold for today's price: (1) DC/AI-infra keeps growing >40% and converts the +400% pipeline on schedule; (2) group adjusted EBITDA margin marches toward 16% by FY29; (3) the ~2.4x adjusted-vs-GAAP add-back gap stays "one-time"; (4) no goodwill impairment / adverse JV ruling; (5) buybacks continue despite higher leverage.
• If growth disappoints 20–30%: Adjusted EPS growth halves to low-single-digits (bear ~$7.3 FY28), the premium multiple compresses toward peers/AECOM, and you can see ~20–30% downside to ~$95–100.
• Single scenario that permanently impairs: A multi-year AI-capex retrenchment that turns the +400% pipeline into slipped/cancelled projects, coincident with a goodwill write-down (42% of assets) and an adverse Consolidated-JV final ruling — hitting earnings, book value and the multiple simultaneously. Plausibility: low-to-moderate (the buildout is real and early), but non-trivial and un-cushioned.

Lens 14 · Management Questions (ordered by information value)

1. Of the +400% data-center pipeline, what fraction is contracted backlog vs. identified opportunity, and what is your realistic conversion rate and schedule to billed net revenue over FY26–FY28?
2. How much of the ~14.6–14.9% FY26 adjusted EBITDA margin is mix (DC/PA) vs. cost action — and what pulls you to the 16%+ FY29 target if DC growth normalizes?
3. Post the £1.2B PA buyout, net debt is ~2.3x adjusted EBITDA. What is your target leverage, and does it pause buybacks or constrain M&A if the AI-capex cycle softens?
4. What is the actual operating margin of the data-center/Advanced-Facilities work vs. the I&AF segment average (~8%) — is DC accretive or just additive?
5. Your GAAP-to-adjusted EPS gap was ~2.4x in FY2025. Which of the recurring "restructuring/transaction" add-backs will still exist in FY2027, and when does the P&L stop carrying separation/PA-deal charges entirely?
6. How exposed is the DC franchise to hyperscaler capex concentration — name-level, what share of DC net revenue is your top 3 clients (NVIDIA/Hut 8/PsiQuantum-type)?
7. On the Consolidated JV Matter: range of potential final outcomes, timing, and worst-case P&L/cash impact?
8. Goodwill is 42% of assets. Under what demand scenario would I&AF or PA goodwill face an impairment test, and how much headroom exists today?
9. What is the incremental margin on the next dollar of DC/AI-infra net revenue vs. legacy infrastructure — i.e., quantify the operating leverage bulls are underwriting?
10. AECOM trades ~33% cheaper on higher margins. What do you do operationally that justifies Jacobs' premium multiple to a shareholder choosing between you?
11. Talent is the binding constraint. What is engineering-headcount wage inflation and attrition in mission-critical/DC, and can you staff the pipeline without eroding margin?
12. Capital-allocation priority stack for the next 3 years: buybacks vs. de-lever vs. tuck-in M&A vs. dividend growth — in order?
13. PA Consulting at 100% ownership: what is the standalone organic growth and margin outlook, and is there integration/dis-synergy risk now that the minority is bought out?
14. FCF margin guide is 7–8.5% vs. a 10%+ FY29 target — what specifically closes that gap, and how does DSO/working-capital (receivables rose ~$567M in H1) behave as DC scales?
15. If the AI-data-center investment cycle is "still in early stages," what would tell you first that it has turned — the leading indicator you watch internally?

---